Pfizer Inc
PFE· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|---|
| Revenue | $13.97B | $16.49B | $17.13B | $10.98B |
| Net Income | $3.25B | $2.61B | $2.48B | $2.26B |
| EPS Diluted | $0.43 |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $0.33 |
| $0.31 |
| $0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.